Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57. Published online 2020 Nov 19 DOI: https://doi.org/10.3350/cmh.2020.0181
|
Citations to this article as recorded by
The prediction of liver decompensation using hepatic collagen deposition assessed by computer-assisted image analysis with Masson’s trichrome stain
Hae Won Yoo, Jae Woo Park, Min Jung Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
Scandinavian Journal of Gastroenterology.2024; 59(1): 85. CrossRef Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
Vlad Ratziu, Marcus Hompesch, Mathieu Petitjean, Cindy Serdjebi, Janani S. Iyer, Anil V. Parwani, Dean Tai, Elisabetta Bugianesi, Kenneth Cusi, Scott L. Friedman, Eric Lawitz, Manuel Romero-Gómez, Detlef Schuppan, Rohit Loomba, Valérie Paradis, Cynthia Be
Journal of Hepatology.2024; 80(2): 335. CrossRef AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
Feng Liu, Yameng Sun, Dean Tai, Yayun Ren, Elaine L. K. Chng, Aileen Wee, Pierre Bedossa, Rui Huang, Jian Wang, Lai Wei, Hong You, Huiying Rao
Diagnostics.2024; 14(16): 1837. CrossRef Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, Mathieu Petitjean
Scientific Reports.2024;[Epub] CrossRef Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee
Gut and Liver.2024; 18(3): 509. CrossRef Potential role of predictive models in assessment of liver inflammation in patients with hepatocellular carcinoma: a two-center cohort study
Wei Xu, Bolun Li, Huai Gong, Jingdong Li, Zhanwei Yang, Yu Liu
European Journal of Medical Research.2024;[Epub] CrossRef NAFLD, MAFLD and obesity: brothers in arms?
Mariana Verdelho Machado, Helena Cortez-Pinto
Nature Reviews Gastroenterology & Hepatology.2023; 20(2): 67. CrossRef Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis
Heechul Nam, Jeong-Ju Yoo, Yuri Cho, Seong Hee Kang, Sang Bong Ahn, Hye-Won Lee, Dae Won Jun, Do Seon Song, Miyoung Choi
Digestive and Liver Disease.2023; 55(9): 1178. CrossRef Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Seung Min Lee, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(1): 171. CrossRef Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
Arun J. Sanyal, Patricia Lopez, Eric J. Lawitz, Kathryn J. Lucas, Juergen Loeffler, Won Kim, George B. B. Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H. Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M. Sheikh, John
Nature Medicine.2023; 29(2): 392. CrossRef Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
Clinical and Molecular Hepatology.2023; 29(Suppl): S157. CrossRef Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
Jung Hwan Yu, Han Ah Lee, Seung Up Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S136. CrossRef Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clinical and Molecular Hepatology.2023; 29(Suppl): S103. CrossRef Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S5. CrossRef Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and
future
Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
Clinical and Molecular Hepatology.2023; 29(Suppl): S171. CrossRef Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato
Computational and Structural Biotechnology Journal.2023; 21: 2495. CrossRef Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
Beom K. Kim, Nicole Bernstein, Daniel Q. Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajim
Alimentary Pharmacology & Therapeutics.2023; 58(2): 229. CrossRef Diagnóstico, tratamiento y complicaciones actualizadas de la enfermedad de hígado graso no alcohólico
Nicole Estefanía Rivadeneira Poveda, Verónica Cristina Jurado Melo
Anatomía Digital.2023; 6(1.2): 6. CrossRef Artifacts in two-dimensional shear wave elastography of liver
Hui-Peng Wang, Peng-Chao Zheng, Xue-Mei Wang, Liang Sang
World Journal of Gastroenterology.2023; 29(21): 3318. CrossRef Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
Alimentary Pharmacology & Therapeutics.2023; 58(3): 322. CrossRef Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee
Ultrasonography.2023; 42(3): 421. CrossRef AutoFibroNet: A deep learning and multi‐photon microscopy‐derived automated network for liver fibrosis quantification in MAFLD
Huiling Zhan, Siyu Chen, Feng Gao, Guangxing Wang, Sui‐Dan Chen, Gangqin Xi, Hai‐Yang Yuan, Xiaolu Li, Wen‐Yue Liu, Christopher D. Byrne, Giovanni Targher, Miao‐Yang Chen, Yong‐Feng Yang, Jun Chen, Zhiwen Fan, Xitai Sun, Guorong Cai, Ming‐Hua Zheng, Shuan
Alimentary Pharmacology & Therapeutics.2023; 58(6): 573. CrossRef Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
Gut and Liver.2023; 17(4): 610. CrossRef Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
International Journal of Cancer.2023; 153(8): 1448. CrossRef Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
Yahui Wen, Heng Zhang, Ning Yang, Xia Gao, Zhe Chen, Jia Liu, Guang Wang
Frontiers in Endocrinology.2023;[Epub] CrossRef Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
Hepatology.2023; 78(6): 1858. CrossRef Diagnosis of liver fibrosis using digital analysis
Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Radosław Dzik, Agata Kabała-Dzik
Diagnostyka Laboratoryjna.2023; 59(2): 65. CrossRef Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation
Yu Rim Shin, Seung Up Kim, Sak Lee, Jae Young Choi, Han Ki Park, Jeong Eun Yoo, Young Nyun Park
The Journal of Thoracic and Cardiovascular Surgery.2022; 164(4): 1176. CrossRef Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Young Jang, Soo Young Park, Hyun Woong Lee, Chun Kyon Lee, Seung Up Kim
Frontiers in Medicine.2022;[Epub] CrossRef Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH
Nikolai V. Naoumov, Dominique Brees, Juergen Loeffler, Elaine Chng, Yayun Ren, Patricia Lopez, Dean Tai, Sophie Lamle, Arun J. Sanyal
Journal of Hepatology.2022; 77(5): 1399. CrossRef The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He
Journal of Translational Medicine.2022;[Epub] CrossRef Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
Journal of Hepatology.2022; 77(6): 1482. CrossRef Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
Abdominal Radiology.2022; 47(11): 3733. CrossRef Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study
Wei Xu, Bolun Li, Zhanwei Yang, Jingdong Li, Fei Liu, Yu Liu
Journal of Hepatocellular Carcinoma.2022; Volume 9: 751. CrossRef Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza
Nutrients.2021; 13(2): 494. CrossRef The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
James Neuberger, Owen Cain
Hepatic Medicine: Evidence and Research.2021; Volume 13: 59. CrossRef Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
Scientific Reports.2021;[Epub] CrossRef Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
I-Ting Liu, Chia-Sheng Yen, Wen-Lung Wang, Hung-Wen Tsai, Chang-Yao Chu, Ming-Yu Chang, Ya-Fu Hou, Chia-Jui Yen
Cancers.2021; 13(21): 5323. CrossRef Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring
Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski
JCI Insight.2021;[Epub] CrossRef
|